CEDARS-SINAI MEDICAL CENTER
- Type
- Teaching hospital
- Where
- Los Angeles, CA
- Medicare CCN
- 050625
- Received
- $40,156,592 in 1,674 records, 2019 ($25,877,253 general, $14,279,339 research)
- Source
- CMS Open Payments search ↗
On this site
- Business registration: Cedars-Sinai Medical Center Fuzzy (name and state)
- Business registration: CEDARS-SINAI MEDICAL CENTER Fuzzy (name and state)
- Nonprofit contractor: CEDARS-SINAI MEDICAL CENTER Fuzzy (name and state)
- Plan sponsor: CEDARS-SINAI MEDICAL CENTER Fuzzy (name and state)
- Federal award recipient: CEDARS-SINAI MEDICAL CENTER Fuzzy (name and state)
- Lobbying client: CEDARS-SINAI MEDICAL CENTER Fuzzy (name and state)
- Lobbying client: CEDARS-SINAI MEDICAL CENTER Fuzzy (name and state)
- Lobbying client: CEDARS-SINAI MEDICAL CENTER Fuzzy (name and state)
- Lobbying client: CEDARS-SINAI MEDICAL CENTER Fuzzy (name and state)
- Lobbying registrant: CEDARS-SINAI MEDICAL CENTER Fuzzy (name and state)
- Patent assignee: CEDARS-SINAI MEDICAL CENTER Fuzzy (name and state)
- Trademark owner: Cedars-Sinai Medical Center Fuzzy (name and state)
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2019 | General payment | 499 | $25,877,253 |
| 2019 | Research payment | 1,175 | $14,279,339 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Royalty or License | 13 | $23,155,614 |
| Research payment | 1,175 | $14,279,339 |
| Grant | 114 | $1,520,556 |
| Education | 121 | $437,738 |
| Space rental or facility fees (teaching hospital only) | 106 | $275,050 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 15 | $177,210 |
| Charitable Contribution | 65 | $159,671 |
| Consulting Fee | 8 | $118,264 |
| Gift | 54 | $17,077 |
| Honoraria | 2 | $11,070 |
| Compensation for serving as faculty or as a speaker for an accredited or certified continuing educat | 1 | $5,000 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2019-12-31 | Monteris Medical Corporation | $18,400 | Grant | In-kind items and services | Neuroblate Device, Neuroblate | 2019 | |
| 2019-12-31 | Abbott Laboratories | $18,000 | Research payment | Cash or cash equivalent | Mitra Clip system Device, Vascular | Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitr | 2019 |
| 2019-12-31 | Allergan, Inc. | $17,303 | Research payment | Cash or cash equivalent | AURORA A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $12,436 | Research payment | In-kind items and services | C-MAC System Device, Airway | Evaluation of Utility of Bronchoscopy After Urgent Intubation | 2019 |
| 2019-12-31 | DJO, LLC | $8,635 | Research payment | Cash or cash equivalent | CMF OL1000 Device, Osteogenesis Stimulators | Prospective, Randomized, Double-Blinded, Controlled Multi-Center Clinical Trial Evaluating the Use of Non-Invasive CMF B | 2019 |
| 2019-12-31 | FUJIFILM SonoSite, Inc. | $5,777 | Education | In-kind items and services | Edge/Edge II Ultrasound System Device, Medical Device | 2019 | |
| 2019-12-31 | DJO, LLC | $4,785 | Research payment | Cash or cash equivalent | CMF OL1000 Device, Osteogenesis Stimulators | Prospective, Randomized, Double-Blinded, Controlled Multi-Center Clinical Trial Evaluating the Use of Non-Invasive CMF B | 2019 |
| 2019-12-31 | KARL STORZ Endoscopy-America | $4,419 | Education | In-kind items and services | HIGH PRESSURE HOSE F/26410005 LAPAROFLAT Device, OTHER MISC | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $4,419 | Education | In-kind items and services | HIGH PRESSURE HOSE F/26410005 LAPAROFLAT Device, OTHER MISC | 2019 | |
| 2019-12-31 | AstraZeneca Pharmaceuticals LP | $4,164 | Research payment | In-kind items and services | Efficacy and Safety Study of Cediranib in Combination With Olaparib in Patients With Recurrent Platinum Resistant Ovaria | 2019 | |
| 2019-12-31 | AstraZeneca Pharmaceuticals LP | $3,921 | Research payment | In-kind items and services | TAGRISSO Drug, Oncology | To assess the efficacy and safety of AZD9291 versus Placebo in patients with Epidermal Growth Factor Receptor Mutation P | 2019 |
| 2019-12-31 | KARL STORZ Endoscopy-America | $3,740 | Education | In-kind items and services | FLEXIBLE INTUB. VIDEO SCOPE KIT, 4.0MM Device, ANESTHESIOLOGY | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $3,711 | Education | In-kind items and services | C-MAC POWER SUPPLY REPLACEMENT F/8403ZX Device, ANESTHESIOLOGY | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $3,603 | Education | In-kind items and services | FLEX. INTUBATION VIDEO SCOPE, 4.0 X 65CM Device, ANESTHESIOLOGY | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $3,295 | Education | In-kind items and services | ADAPTER,XLINK,VIDEOENDOSCOPE Device, VIDEOIMAGING | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $3,114 | Education | In-kind items and services | POWER LED 175 LIGHT SOURCE W/SCB Device, VIDEOIMAGING | 2019 | |
| 2019-12-31 | Zimmer Biomet Holdings, Inc. | $2,709 | Gift | In-kind items and services | Zimmer Biomet Instruments and Implants Device, General | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $2,103 | Education | In-kind items and services | TUBE,PROTECTING,PLASTIC.19.7CM Device, ENT | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $2,031 | Education | In-kind items and services | CCU,MODULAR,IMAGE1 S X-LINK,US Device, VIDEOIMAGING | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $1,779 | Education | In-kind items and services | CCU,MODULAR,IMAGE1 CONNECT,US Device, VIDEOIMAGING | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $1,746 | Education | In-kind items and services | DRILLCUT-X II SHAVER HANDPIECE Device, ENT | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $1,738 | Education | In-kind items and services | 7 FLAT PANEL MONITOR ONLY F/C-MAC, HDMI Device, ANESTHESIOLOGY | 2019 | |
| 2019-12-31 | DJO, LLC | $1,570 | Research payment | Cash or cash equivalent | CMF OL1000 Device, Osteogenesis Stimulators | Prospective, Randomized, Double-Blinded, Controlled Multi-Center Clinical Trial Evaluating the Use of Non-Invasive CMF B | 2019 |
| 2019-12-31 | Zimmer Biomet Holdings, Inc. | $1,478 | Gift | In-kind items and services | Zimmer Biomet Instruments and Implants Device, General | 2019 | |
| 2019-12-31 | AstraZeneca Pharmaceuticals LP | $1,474 | Research payment | In-kind items and services | This is a randomized open label multi center global Phase III study to assess the efficacy and safety of durvalumab plus | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $1,354 | Education | In-kind items and services | LAMP MODULE,SPARE, XENON,WITH HEAT SINK Device, VIDEOIMAGING | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $1,257 | Education | In-kind items and services | TELESCOPE,HOPKINS II,AUTOCLAVABLE Device, LAPAROSCOPY | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $1,221 | Education | In-kind items and services | CCU, C-HUB II, CMOS CAMERA CONTROL UNIT Device, VIDEOIMAGING | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $1,193 | Education | In-kind items and services | TELESCOPE,HOPKINS II,AUTOCLAVABLE, Device, LAPAROSCOPY | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $1,162 | Education | In-kind items and services | TELESCOPE,HOPKINS II, 30, 5mm x 29cm Device, LAPAROSCOPY | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $926 | Education | In-kind items and services | TELESCOPE,HOPKINS II, 30, 5mm x 29cm Device, LAPAROSCOPY | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $701 | Education | In-kind items and services | VARIABLE HEIGHT SECONDARY MONITOR STAND Device, VIDEOIMAGING | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $695 | Education | In-kind items and services | OUTER TUBE, CLICKLINE, W/CENTIMETER Device, LAPAROSCOPY | 2019 | |
| 2019-12-31 | Masimo Corporation | $691 | Education | In-kind items and services | SedLine Device, Devices | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $663 | Education | In-kind items and services | SONY UPDR80MD MEDICAL GRADE PRINTER Device, OR1 | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $626 | Research payment | In-kind items and services | ICG System Device, LAPAROSCOPY | Efficacy of Near Infrared Incisionless Fluorescent Cholangiography (NIFC) During Laparoscopic Cholec | 2019 |
| 2019-12-31 | KARL STORZ Endoscopy-America | $521 | Education | In-kind items and services | OUTER TUBE, CLICKLINE, W/CENTIMETER Device, LAPAROSCOPY | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $480 | Education | In-kind items and services | CLAMPING JAW W/BALL JOINT, LRG 16.5-23MM Device, MICRO/NOTES/MILITARY | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $480 | Education | In-kind items and services | CLAMPING JAW W/BALL JOINT, LRG 16.5-23MM Device, MICRO/NOTES/MILITARY | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $478 | Education | In-kind items and services | TELESCOPE,HOPKINS II, FORWARD-OBLIQUE, Device, ENT | 2019 | |
| 2019-12-31 | Linvatec Corporation | $425 | Grant | In-kind items and services | HALL POWER Device, ORTHOPEDIC SURGERY | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $392 | Education | In-kind items and services | NEEDLE HOLDER, 'KOH', MACRO Device, LAPAROSCOPY | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $388 | Education | In-kind items and services | ELECTRONIC IMAGING MODULE F/C-MAC, 8 PIN Device, ANESTHESIOLOGY | 2019 | |
| 2019-12-31 | Siemens Medical Solutions USA, Inc. | $380 | Research payment | Cash or cash equivalent | CSMC2019MRIPR1101IPR1102IPR1103Maya | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $335 | Education | In-kind items and services | CONTAINER SYSTEM, EXTRA LRG Device, CLEANING, STERILIZATION, CARE | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $332 | Education | In-kind items and services | LIGHT CABLE ASSEMBLY, 4.8 MM X 2500MM Device, VIDEOIMAGING | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $330 | Gift | In-kind items and services | FLEXIBLE CYSTOSCOPE, CHNL:7FR, 15FRX37CM Device, UROLOGY | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $307 | Education | In-kind items and services | 32 inch 4K MONITOR Device, VIDEOIMAGING | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $299 | Education | In-kind items and services | EXTENSION ROD, ARTICULATED STAND 50CM Device, MICRO/NOTES/MILITARY | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $287 | Education | In-kind items and services | POLE STAND FOR VIDEO INTUBATION PLATFORM Device, ANESTHESIOLOGY | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $259 | Education | In-kind items and services | HOLDING SYSTEM ROTATION SOCKET ONLY Device, LAPAROSCOPY | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $252 | Education | In-kind items and services | CLAMPING JAW W/BALL JOINT, LRG 16.5-23MM Device, MICRO/NOTES/MILITARY | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $252 | Education | In-kind items and services | INSERT ATRAUMATIC GRASPING Device, LAPAROSCOPY | 2019 | |
| 2019-12-31 | Masimo Corporation | $221 | Education | In-kind items and services | Patient SafetyNet System Device, Devices | 2019 | |
| 2019-12-31 | Siemens Medical Solutions USA, Inc. | $218 | Research payment | Cash or cash equivalent | CSMC2019MRIPR785Xie | 2019 | |
| 2019-12-31 | AstraZeneca Pharmaceuticals LP | $208 | Research payment | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | Forxiga HF-D1699C00001 HF rEF Outcome study | 2019 |
| 2019-12-31 | KARL STORZ Endoscopy-America | $185 | Education | In-kind items and services | CBL, 33 FOOT (10M) DVI CABLE Device, VIDEOIMAGING | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $173 | Education | In-kind items and services | ]]BE,OUTER,METAL,W/LUER-LOCK Device, LAPAROSCOPY | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $162 | Education | In-kind items and services | LIGHT CABLE, 3.5MM X 300CM. LGTH 9.8 FT Device, VIDEOIMAGING | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $162 | Education | In-kind items and services | LIGHT CABLE ASSEMBLY, 4.8 MM X 2500MM Device, VIDEOIMAGING | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $162 | Education | In-kind items and services | TUBE,OUTER,INSULATED,W/LUER- Device, LAPAROSCOPY | 2019 | |
| 2019-12-31 | Zimmer Biomet Holdings, Inc. | $142 | Gift | In-kind items and services | Zimmer Biomet Instruments and Implants Device, General | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $139 | Education | In-kind items and services | HANDLE,METAL,HEMOSTAT RATCHET Device, LAPAROSCOPY | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $139 | Education | In-kind items and services | CLICKLINE METAL HANDLE, WITHOUT RATCHET Device, LAPAROSCOPY | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $139 | Education | In-kind items and services | INSERT,BERCI,FORCEPS, PADDED Device, LAPAROSCOPY | 2019 | |
| 2019-12-31 | Masimo Corporation | $126 | Education | In-kind items and services | EMMA and ISA Device, Devices | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $126 | Education | In-kind items and services | INSERT,'KELLY',DISSECT/GRASP, Device, LAPAROSCOPY | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $126 | Education | In-kind items and services | INSERT,BOWEL GRASPER,FENESTRAT Device, LAPAROSCOPY | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $126 | Education | In-kind items and services | INSERT,'BERCI',GRASP,MULTI- Device, LAPAROSCOPY | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $126 | Education | In-kind items and services | INSERT, FORCEPS Device, LAPAROSCOPY | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $126 | Education | In-kind items and services | INSERT,DISSECT,RIGHT ANGLE,DBL Device, LAPAROSCOPY | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $126 | Education | In-kind items and services | INSERT,'KELLY',DISSECT/GRASP, Device, LAPAROSCOPY | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $126 | Education | In-kind items and services | INSERT,BOWEL GRASPER,FENESTRAT Device, LAPAROSCOPY | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $126 | Education | In-kind items and services | INSERT,SCISSORS,SERRATED JAWS, Device, LAPAROSCOPY | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $126 | Education | In-kind items and services | FORCEP INSERT, ATRAUMATIC Device, LAPAROSCOPY | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $126 | Education | In-kind items and services | INSERT, CROCE-OLMI',GRASP, Device, LAPAROSCOPY | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $126 | Education | In-kind items and services | INSERT,SCISSORS,SERRATED JAWS, Device, LAPAROSCOPY | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $126 | Education | In-kind items and services | INSERT,SCISSORS,HOOK,SNGL ACTN Device, LAPAROSCOPY | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $126 | Education | In-kind items and services | INSERT,'BABCOCK'GRASP, MULTI Device, LAPAROSCOPY | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $126 | Education | In-kind items and services | FORCEPS,5MM,36CM, Device, LAPAROSCOPY | 2019 | |
| 2019-12-31 | Masimo Corporation | $126 | Education | In-kind items and services | Patient SafetyNet System Device, Devices | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $122 | Education | In-kind items and services | ADAPTER,XLINK,VIDEOENDOSCOPE Device, VIDEOIMAGING | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $110 | Education | In-kind items and services | HANDLE,METAL,INSULATED W/O Device, LAPAROSCOPY | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $110 | Education | In-kind items and services | PLASTIC HANDLE, WITH RATCHET Device, LAPAROSCOPY | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $110 | Education | In-kind items and services | PLASTIC HANDLE, WITH RATCHET Device, LAPAROSCOPY | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $110 | Education | In-kind items and services | CLICKLINE PLASTIC HANDLE,WITHOUT RATCHET Device, LAPAROSCOPY | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $104 | Education | In-kind items and services | CORD,HIGH FREQ,W/8MM PLUG,300CM, Device, OTHER MISC | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $76 | Education | In-kind items and services | BATTERY SHELL F/8546 W/BATTERY AND CAP Device, ANESTHESIOLOGY | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $67 | Education | In-kind items and services | OR1 ORIENTATION SURGEON WORKBOOK Device, OR1 | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $59 | Education | In-kind items and services | CLAMPING CYLINDER FOLDING FOR VITOM Device, MICRO/NOTES/MILITARY | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $42 | Education | In-kind items and services | VITOM DISTANCE ROD Device, MICRO/NOTES/MILITARY | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $37 | Education | In-kind items and services | TUBE HOLDER FOR VIDEO ENDOSCOPES Device, ANESTHESIOLOGY | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $35 | Education | In-kind items and services | CABLE, HDMI (M) TO DVI-D (M), 15 FT Device, OR1 | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $30 | Gift | In-kind items and services | LIGHT CABLE, 3.5MM X 300CM. LGTH 9.8 FT Device, VIDEOIMAGING | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $30 | Gift | In-kind items and services | CORD,HIGH FREQUENCY,BIPOLAR. Device, OTHER MISC | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $29 | Education | In-kind items and services | LIGHT CABLE ASSEMBLY, 4.8 MM X 3000MM Device, VIDEOIMAGING | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $24 | Education | In-kind items and services | BLUE PRO-TIES, ONE BOX OF 6 TIES Device, MICRO/NOTES/MILITARY | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $23 | Education | In-kind items and services | REPLACEMENT PADS,SILICONE,PKG OF 10 Device, OTHER MISC | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $16 | Education | In-kind items and services | HANDLE,ONLY.F/LARYNGOSCOPE Device, ANESTHESIOLOGY | 2019 | |
| 2019-12-31 | KARL STORZ Endoscopy-America | $6 | Education | In-kind items and services | BUTTERFLY NUT TO 28172HK Device, LAPAROSCOPY | 2019 | |
| 2019-12-31 | Zimmer Biomet Holdings, Inc. | $0 | Gift | In-kind items and services | Zimmer Biomet Instruments and Implants Device, General | 2019 | |
| 2019-12-31 | Zimmer Biomet Holdings, Inc. | $0 | Gift | In-kind items and services | Zimmer Biomet Instruments and Implants Device, General | 2019 | |
| 2019-12-30 | Medical Device Business Services, Inc. | $46,933 | Research payment | Cash or cash equivalent | CERTUS 140 MICROWAVE ABLATION SYSTEM Device, Interventional Solutions | Retrospective Review of the Use of Microwave Ablation in the Treatment of Patients with Both Metastatic Disease to the L | 2019 |
| 2019-12-30 | Otsuka Pharmaceutical Co., Ltd. | $22,898 | Research payment | Cash or cash equivalent | A PHASE 1-2 STUDY OF THE SAFETY, PHARMACOKINETICS, AND ACTIVITY OF ASTX029 IN SUBJECTS WITH ADVANCED SOLID TUMORS | 2019 | |
| 2019-12-30 | ABBVIE INC. | $2,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Rinvoq Biological, Immunology | 2019 | |
| 2019-12-30 | ABBVIE INC. | $2,446 | Research payment | Cash or cash equivalent | Skyrizi Biological, Immunology | M16-066 | 2019 |
| 2019-12-30 | Fisher Scientific Company L.L.C. | $10 | Research payment | In-kind items and services | sFlt-1 Device, prenatal screening | Identification and validation of a cut-off for the ratio of suluble Fms-like Tyrosine Kinase-1 to Placental Growth Facto | 2019 |
| 2019-12-27 | Medical Device Business Services, Inc. | $7,500 | Grant | Cash or cash equivalent | 2019 | ||
| 2019-12-27 | PFIZER INC. | $4,200 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2019 |
| 2019-12-27 | Wilson Cook Medical Incorporated | $3,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2019 | ||
| 2019-12-26 | Paragon 28, Inc. | $18,362 | Research payment | Cash or cash equivalent | Device, foot and ankle implants | A Retrospective Review of Gorilla Calc Slide Plate | 2019 |
| 2019-12-26 | United Therapeutics Corporation | $4,615 | Research payment | Cash or cash equivalent | ORENITRAM Drug, PAH | A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF ORAL TREPROSTIN | 2019 |
| 2019-12-26 | United Therapeutics Corporation | $3,230 | Research payment | Cash or cash equivalent | ORENITRAM Drug, PAH | AN OPEN-LABEL EXTENSION STUDY OF ORAL TREPROSTINIL IN SUBJECTS WITH PULMONARY HYPERTENSION PH ASSOCIATED WITH HEART FAIL | 2019 |
| 2019-12-26 | Bayer Healthcare Pharmaceuticals Inc. | $3,125 | Research payment | Cash or cash equivalent | Nexavar Drug, Oncology | 060204 - Clinical Trial Pase IV (Post Marketing) (Bayer Product or TA) | 2019 |
| 2019-12-26 | Bayer Healthcare Pharmaceuticals Inc. | $3,125 | Research payment | Cash or cash equivalent | Nexavar Drug, Oncology | 060204 - Clinical Trial Pase IV (Post Marketing) (Bayer Product or TA) | 2019 |
| 2019-12-26 | Bayer Healthcare Pharmaceuticals Inc. | $3,125 | Research payment | Cash or cash equivalent | Nexavar Drug, Oncology | 060204 - Clinical Trial Pase IV (Post Marketing) (Bayer Product or TA) | 2019 |
| 2019-12-26 | Janssen Research & Development, LLC | $1,104 | Research payment | Cash or cash equivalent | A Randomized, Double-blind, Placebo-controlled Phase 3 Study of JNJ-56021927 in Subjects with High-risk, Localized or Lo | 2019 | |
| 2019-12-26 | Bayer Healthcare Pharmaceuticals Inc. | $437 | Research payment | Cash or cash equivalent | Nexavar Drug, Oncology | 060204 - Clinical Trial Pase IV (Post Marketing) (Bayer Product or TA) | 2019 |
| 2019-12-24 | Merck Sharp & Dohme LLC | $16,239 | Research payment | In-kind items and services | LENVIMA Drug, ONCOLOGY | A Multicenter, Open-label Phase 2 Study of Lenvatinib E7080,MK-7902 Plus Pembrolizumab MK-3475 in Previously Treated Sub | 2019 |
| 2019-12-24 | Merck Sharp & Dohme LLC | $1,542 | Research payment | In-kind items and services | LENVIMA Drug, ONCOLOGY | A Multicenter, Open-label Phase 2 Study of Lenvatinib E7080,MK-7902 Plus Pembrolizumab MK-3475 in Previously Treated Sub | 2019 |
| 2019-12-23 | Exelixis Inc. | $11,544 | Research payment | Cash or cash equivalent | Cabozantinib Drug, Oncology | Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors | 2019 |
| 2019-12-23 | GlaxoSmithKline, LLC. | $5,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | BENLYSTA Biological, IMMUNOLOGY | 2019 | |
| 2019-12-23 | Janssen Biotech, Inc. | $2,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | SIMPONI ARIA Biological, Immunology | 2019 | |
| 2019-12-23 | Exelixis Inc. | $2,399 | Research payment | Cash or cash equivalent | Cabozantinib Drug, Oncology | Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors | 2019 |
| 2019-12-23 | Exelixis Inc. | $1,688 | Research payment | Cash or cash equivalent | Cabozantinib Drug, Oncology | Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors | 2019 |
| 2019-12-23 | TESARO, Inc. | $1,638 | Research payment | Cash or cash equivalent | A PHASE 1 DOSE ESCALATION AND COHORT EXPANSION STUDY OF TSR-022, AN ANTI-TIM-3 MONOCLONAL ANTIBODY, IN PATIENTS WITH ADV | 2019 | |
| 2019-12-23 | Exelixis Inc. | $1,137 | Research payment | Cash or cash equivalent | Cabozantinib Drug, Oncology | Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors | 2019 |
| 2019-12-20 | ABBVIE INC. | $13,300 | Research payment | Cash or cash equivalent | Skyrizi Biological, Immunology | M16-067 | 2019 |
| 2019-12-20 | GE HEALTHCARE | $9,543 | Research payment | Cash or cash equivalent | A PHASE 3 OPEN LABEL MULTICENTRE STUDY OF FLURPIRIDAZ (18F) INJECTION FOR POSITRON EMISSION TOMOGRAPHY (PET) IMAGING FOR | 2019 | |
| 2019-12-20 | ABBVIE INC. | $7,531 | Research payment | Cash or cash equivalent | Humira Biological, Immunology | P11-292 | 2019 |
| 2019-12-20 | Stryker Corporation | $7,165 | Research payment | Cash or cash equivalent | VARIAX Device, TRAUMA & EXTREMETIES | A RETROSPECTIVE DATA DOLLECTION OF THE TREATMENT OF CLAVICLE FRACTURES WITH THE VARIAX CLAVICLE LOCKING PLATE SYSTEM | 2019 |
| 2019-12-20 | ABBVIE INC. | $325 | Research payment | Cash or cash equivalent | Skyrizi Biological, Immunology | M16-067 | 2019 |
| 2019-12-20 | Merck Sharp & Dohme LLC | $97 | Research payment | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | A Randomized, Double-Blind, Phase 3 Study of Pemetrexed Platinum Chemotherapy with or without Pembrolizumab MK-3475 in | 2019 |
| 2019-12-19 | Edwards Lifesciences Corporation | $134,837 | Research payment | Cash or cash equivalent | PARTNER3 2015-08 | 2019 | |
| 2019-12-19 | Brahms GmbH | $75,000 | Research payment | Cash or cash equivalent | BRAHMS sFlt-1 KRYPTOR Device, prenatal screening | Identification and validation of a cut-off for the ratio of suluble Fms-like Tyrosine Kinase-1 to Placental Growth Facto | 2019 |
| 2019-12-19 | Merck Sharp & Dohme LLC | $1,065 | Research payment | In-kind items and services | LENVIMA Drug, ONCOLOGY | A Multicenter, Open-label Phase 2 Study of Lenvatinib E7080,MK-7902 Plus Pembrolizumab MK-3475 in Previously Treated Sub | 2019 |
| 2019-12-19 | Merck Sharp & Dohme LLC | $659 | Research payment | In-kind items and services | MK-7339 Drug, ONCOLOGY | A Phase 2 Study of Olaparib Monotherapy in Participants with Previously Treated, Homologous Recombination Repair Mutatio | 2019 |
| 2019-12-18 | Gilead Sciences, Inc. | $44,709 | Research payment | Cash or cash equivalent | A Proof of Concept, Open-Label Study Evaluating the Safety, Tolerability, and Efficacy of Monotherapy and Combination Re | 2019 | |
| 2019-12-18 | Gilead Sciences, Inc. | $15,474 | Research payment | Cash or cash equivalent | Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib | 2019 | |
| 2019-12-18 | Edwards Lifesciences Corporation | $13,600 | Research payment | Cash or cash equivalent | Edwards PASCAL Transcatheter Valve Repair System in Tricuspid Regurgitation CLASP TR Early Feasibility Study | 2019 | |
| 2019-12-18 | Exelixis Inc. | $10,000 | Grant | Cash or cash equivalent | Cabometyx Drug, Oncology | 2019 | |
| 2019-12-18 | Gilead Sciences, Inc. | $176 | Research payment | Cash or cash equivalent | A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Ulcerative Colitis | 2019 | |
| 2019-12-18 | Gilead Sciences, Inc. | $104 | Research payment | Cash or cash equivalent | A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of Cilof | 2019 | |
| 2019-12-17 | Merck Sharp & Dohme LLC | $10,826 | Research payment | In-kind items and services | LENVIMA Drug, ONCOLOGY | A Multicenter, Open-label Phase 2 Study of Lenvatinib E7080,MK-7902 Plus Pembrolizumab MK-3475 in Previously Treated Sub | 2019 |
| 2019-12-17 | Genentech, Inc. | $5,755 | Research payment | Cash or cash equivalent | Drug | TENECTEPLASE IN STROKE PATIENTS BETWEEN 4 5 AND 24 HOURS | 2019 |
| 2019-12-17 | Merck Sharp & Dohme LLC | $4,985 | Research payment | Cash or cash equivalent | KEYTRUDA Biological, ONCOLOGY | A Clinical Trial of Pembrolizumab MK-3475 Evaluating Predictive Biomarkers in Subjectswith Advanced Solid Tumors KEYNOTE | 2019 |
| 2019-12-17 | EMD Serono, Inc. | $3,827 | Research payment | Cash or cash equivalent | Bavencio Biological, Oncology | EMR 100070-001 | 2019 |
| 2019-12-17 | Medical Device Business Services, Inc. | $2,976 | Grant | Cash or cash equivalent | 2019 | ||
| 2019-12-17 | Merck Sharp & Dohme LLC | $1,542 | Research payment | In-kind items and services | LENVIMA Drug, ONCOLOGY | A Multicenter, Open-label Phase 2 Study of Lenvatinib E7080,MK-7902 Plus Pembrolizumab MK-3475 in Previously Treated Sub | 2019 |
| 2019-12-16 | Edwards Lifesciences Corporation | $138,415 | Research payment | Cash or cash equivalent | SM3 Trial 2017-03 | 2019 | |
| 2019-12-16 | Edwards Lifesciences Corporation | $55,031 | Research payment | Cash or cash equivalent | Early-TAVR Trial 2016-07 | 2019 | |
| 2019-12-16 | Boston Scientific Corporation | $6,397 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | REPRISE III | 2019 |
| 2019-12-16 | Boston Scientific Corporation | $5,854 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | PINNACLE FLX | 2019 |
| 2019-12-16 | Gilead Sciences, Inc. | $3,457 | Research payment | Cash or cash equivalent | A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Crohn's Disease | 2019 | |
| 2019-12-16 | Gilead Sciences, Inc. | $3,397 | Research payment | Cash or cash equivalent | Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib | 2019 | |
| 2019-12-16 | Gilead Sciences, Inc. | $2,857 | Research payment | Cash or cash equivalent | A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Ulcerative Colitis | 2019 | |
| 2019-12-16 | Medtronic Vascular, Inc. | $2,221 | Research payment | Cash or cash equivalent | Viva Device, Implantable Cardioverter Defibrillators (ICDs) | AdaptResponse | 2019 |
| 2019-12-16 | Boston Scientific Corporation | $273 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | ASAP TOO | 2019 |
| 2019-12-14 | MEDIVATION LLC. | $34,645 | Research payment | In-kind items and services | XTANDI Drug, ONCOLOGY | A PHASE 3 RANDOMIZED EFFICACY AND SAFETY STUDY OF ENZALUTAMIDE PLUS LEUPROLIDE ENZALUTAMIDE MONOTHERAPY AND PLACEBO PLUS | 2019 |
| 2019-12-13 | Edwards Lifesciences Corporation | $4,350 | Research payment | Cash or cash equivalent | CLASP IIF 2018-07 | 2019 | |
| 2019-12-13 | Takeda Pharmaceuticals U.S.A., Inc. | $3,500 | Education | Cash or cash equivalent | ENTYVIO Biological, Lower GI | 2019 | |
| 2019-12-13 | Shire North American Group Inc | $1,592 | Research payment | Cash or cash equivalent | GATTEX Drug, INTERNAL MEDICINE | A PROSPECTIVE, MULTI-CENTER REGISTRY FOR PATIENTS WITH SHORT BOWEL SYNDROME | 2019 |
| 2019-12-13 | Shire North American Group Inc | $1,592 | Research payment | Cash or cash equivalent | GATTEX Drug, INTERNAL MEDICINE | A PROSPECTIVE, MULTI-CENTER REGISTRY FOR PATIENTS WITH SHORT BOWEL SYNDROME | 2019 |
| 2019-12-13 | Shire North American Group Inc | $1,102 | Research payment | Cash or cash equivalent | GATTEX Drug, INTERNAL MEDICINE | A PROSPECTIVE, MULTI-CENTER REGISTRY FOR PATIENTS WITH SHORT BOWEL SYNDROME | 2019 |
| 2019-12-13 | Shire North American Group Inc | $563 | Research payment | Cash or cash equivalent | GATTEX Drug, INTERNAL MEDICINE | A PROSPECTIVE, MULTI-CENTER REGISTRY FOR PATIENTS WITH SHORT BOWEL SYNDROME | 2019 |
| 2019-12-12 | TESARO, Inc. | $34,568 | Research payment | In-kind items and services | ZEJULA Drug, ONCOLOGY | A STUDY OF NIRAPARIB IN PATIENTS WITH OVARIAN CANCER WHO HAVE RECEIVED AT LEAST THREE PREVIOUS CHEMOTHERAPY REGIMENS | 2019 |
| 2019-12-12 | Otsuka Pharmaceutical Co., Ltd. | $30,930 | Research payment | Cash or cash equivalent | STUDY OF ASTX295 IN PATIENTS WITH SOLID TUMORS WITH WILD-TYPE P53 | 2019 | |
| 2019-12-12 | Regeneron Pharmaceuticals, Inc. | $12,228 | Research payment | Cash or cash equivalent | AN OPEN-LABEL STUDY TO EVALUATE THE LONG-TERM SAFETY AND EFFICACY OF EVINACUMAB IN PATIENTS WITH HOMOZYGOUS FAMILIAL HYP | 2019 | |
| 2019-12-12 | Regeneron Pharmaceuticals, Inc. | $8,679 | Research payment | Cash or cash equivalent | AN OPEN-LABEL STUDY TO EVALUATE THE LONG-TERM SAFETY AND EFFICACY OF EVINACUMAB IN PATIENTS WITH HOMOZYGOUS FAMILIAL HYP | 2019 | |
| 2019-12-12 | BioMarin Pharmaceutical Inc. | $5,000 | Grant | Cash or cash equivalent | Vimizim Biological, MPS IVA | 2019 | |
| 2019-12-12 | ABBVIE INC. | $4,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Creon Drug, Endocrinology | 2019 | |
| 2019-12-12 | Merck Sharp & Dohme LLC | $2,200 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | KEYTRUDA Biological, ONCOLOGY | 2019 | |
| 2019-12-12 | Regeneron Pharmaceuticals, Inc. | $1,500 | Research payment | Cash or cash equivalent | A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF VARYING DOSES AND DOSE REGIMENS OF EV | 2019 | |
| 2019-12-12 | Regeneron Pharmaceuticals, Inc. | $975 | Research payment | Cash or cash equivalent | A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF VARYING DOSES AND DOSE REGIMENS OF EV | 2019 | |
| 2019-12-11 | Incyte Corporation | $15,919 | Research payment | Cash or cash equivalent | A Phase 12, Open Label, Dose Escalation, Safety and Tolerability Study of INCAGN01876 in Subjects With Advanced or Metas | 2019 | |
| 2019-12-11 | United Therapeutics Corporation | $2,600 | Research payment | Cash or cash equivalent | TYVASO Drug, PAH | A MULTICENTER RANDOMIZED DOUBLE-BLINDED PLACEBO-CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF INHALED TREPROST | 2019 |
| 2019-12-11 | United Therapeutics Corporation | $2,600 | Research payment | Cash or cash equivalent | TYVASO Drug, PAH | AN OPEN-LABEL EXTENSION STUDY OF INHALED TREPROSTINIL IN SUBJECTS WITH PULMONARY HYPERTENSION DUE TO PARENCHYMAL LUNG DI | 2019 |
| 2019-12-11 | Medtronic, Inc. | $206 | Research payment | Cash or cash equivalent | Attain Device, Leads | PSR-CVG | 2019 |
| 2019-12-10 | Edwards Lifesciences Corporation | $28,995 | Research payment | Cash or cash equivalent | The CLASP Study Edwards PASCAL TrAnScatheter Mitral Valve RePair System Study 2016-05 | 2019 | |
| 2019-12-10 | Boston Scientific Corporation | $27,500 | Grant | Cash or cash equivalent | GENERAL - BILIARY DEVICES Device, BILIARY DEVICES | 2019 | |
| 2019-12-10 | Boston Scientific Corporation | $4,500 | Grant | Cash or cash equivalent | GENERAL - BILIARY DEVICES Device, BILIARY DEVICES | 2019 | |
| 2019-12-10 | Olympus Corporation of the Americas | $2,500 | Grant | Cash or cash equivalent | 2019 | ||
| 2019-12-09 | PFIZER INC. | $27,109 | Research payment | Cash or cash equivalent | XELJANZ Drug, GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | 2019 | |
| 2019-12-09 | Edwards Lifesciences Corporation | $21,575 | Research payment | Cash or cash equivalent | PARTNER3 2015-08 | 2019 | |
| 2019-12-09 | Edwards Lifesciences Corporation | $18,897 | Research payment | Cash or cash equivalent | Trial 2017-18 ExCEED | 2019 | |
| 2019-12-09 | Cook Incorporated | $17,000 | Grant | Cash or cash equivalent | 2019 | ||
| 2019-12-09 | Premia Spine, Ltd. | $13,351 | Research payment | Cash or cash equivalent | TOPS | A Clinical Study to Assess the Safety and Effectiveness of the Premia Spine TOPS System | 2019 |
| 2019-12-09 | Medtronic USA, Inc. | $7,500 | Grant | Cash or cash equivalent | 2019 | ||
| 2019-12-09 | PFIZER INC. | $5,000 | Grant | Cash or cash equivalent | 2019 | ||
| 2019-12-09 | Merck Sharp & Dohme LLC | $2,713 | Research payment | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | A Clinical Trial of Pembrolizumab MK-3475 Evaluating Predictive Biomarkers in Subjectswith Advanced Solid Tumors KEYNOTE | 2019 |
| 2019-12-09 | Merck Sharp & Dohme LLC | $2,713 | Research payment | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | A Clinical Trial of Pembrolizumab MK-3475 Evaluating Predictive Biomarkers in Subjectswith Advanced Solid Tumors KEYNOTE | 2019 |
| 2019-12-09 | Merck Sharp & Dohme LLC | $2,713 | Research payment | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | A Clinical Trial of Pembrolizumab MK-3475 Evaluating Predictive Biomarkers in Subjectswith Advanced Solid Tumors KEYNOTE | 2019 |
| 2019-12-09 | Merck Sharp & Dohme LLC | $2,713 | Research payment | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | A Clinical Trial of Pembrolizumab MK-3475 Evaluating Predictive Biomarkers in Subjectswith Advanced Solid Tumors KEYNOTE | 2019 |
| 2019-12-09 | Merck Sharp & Dohme LLC | $2,713 | Research payment | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | A Clinical Trial of Pembrolizumab MK-3475 Evaluating Predictive Biomarkers in Subjectswith Advanced Solid Tumors KEYNOTE | 2019 |
| 2019-12-09 | Merck Sharp & Dohme LLC | $2,713 | Research payment | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | A Clinical Trial of Pembrolizumab MK-3475 Evaluating Predictive Biomarkers in Subjectswith Advanced Solid Tumors KEYNOTE | 2019 |
| 2019-12-09 | Merck Sharp & Dohme LLC | $2,713 | Research payment | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | A Clinical Trial of Pembrolizumab MK-3475 Evaluating Predictive Biomarkers in Subjectswith Advanced Solid Tumors KEYNOTE | 2019 |
| 2019-12-09 | Merck Sharp & Dohme LLC | $2,713 | Research payment | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | A Clinical Trial of Pembrolizumab MK-3475 Evaluating Predictive Biomarkers in Subjectswith Advanced Solid Tumors KEYNOTE | 2019 |
| 2019-12-09 | Merck Sharp & Dohme LLC | $2,713 | Research payment | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | A Clinical Trial of Pembrolizumab MK-3475 Evaluating Predictive Biomarkers in Subjectswith Advanced Solid Tumors KEYNOTE | 2019 |
| 2019-12-09 | Merck Sharp & Dohme LLC | $2,713 | Research payment | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | A Clinical Trial of Pembrolizumab MK-3475 Evaluating Predictive Biomarkers in Subjectswith Advanced Solid Tumors KEYNOTE | 2019 |
| 2019-12-09 | Merck Sharp & Dohme LLC | $2,713 | Research payment | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | A Clinical Trial of Pembrolizumab MK-3475 Evaluating Predictive Biomarkers in Subjectswith Advanced Solid Tumors KEYNOTE | 2019 |
The latest 200 records of 1,674.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Los Angeles, CA, county Los Angeles County, CA, state California; placed by its city name.
| Measure | Place (city or town) Los Angeles, CA | County Los Angeles County, CA | State California |
|---|---|---|---|
| Population B01003 | 3,857,263 | 9,808,667 | 39,287,377 |
| Population, 2020 census P1 | 3,898,747 | 10,014,009 | 39,538,223 |
| Median age B01002 | 37.2 | 38.2 | 37.9 |
| Under 18 B01001 | 19.2% | 20.6% | 22.0% |
| 65 and over B01001 | 14.2% | 15.2% | 15.7% |
| Households B11001 | 1,439,097 | 3,416,449 | 13,548,091 |
| Foreign born B05002 | 35.7% | 33.4% | 27.0% |
| Median household income B19013 | $81,939 | $90,112 | $99,122 |
| Median family income B19113 | $94,546 | $101,573 | $113,346 |
| Per capita income B19301 | $47,685 | $45,792 | $49,513 |
| Poverty rate B17001 | 16.5% | 13.7% | 12.0% |
| Unemployment rate B23025 | 8.2% | 7.3% | 6.6% |
| Civilian labor force B23025 | 2,128,918 | 5,200,656 | 20,068,466 |
| Mean commute (minutes) B08013 | 30.7 | 30.4 | 28.7 |
| Bachelor's degree or higher B15003 | 38.5% | 36.0% | 37.1% |
| Housing units B25001 | 1,554,332 | 3,650,466 | 14,644,735 |
| Owner-occupied B25003 | 36.0% | 45.9% | 55.9% |
| Renters B25003 | 64.0% | 54.1% | 44.1% |
| Median home value B25077 | $921,200 | $834,200 | $734,700 |
| Median gross rent B25064 | $1,933 | $1,954 | $2,036 |
| White, not Hispanic B03002 | 28.1% | 24.7% | 33.8% |
| Black B03002 | 8.1% | 7.4% | 5.2% |
| Hispanic or Latino B03002 | 47.2% | 48.4% | 40.2% |
| Asian B03002 | 11.9% | 14.9% | 15.3% |
| American Indian and Alaska Native B03002 | 0.1% | 0.2% | 0.3% |
Economy now FRED unemployment 5.1% in Sep 2026 (5.5% a year earlier); per capita personal income $90,957 in 2025, up 30% in five years (+4.3% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Los Angeles, CA.
Comments